Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.31 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21736498 | 0.89 | SMN1; SMN2 (0.32) | SMN1; SMN2LMNAMEN1ALDH1A1POLB | |
| SCHEMBL20670085 | 0.89 | TDP1 (0.33) | SMN1; SMN2LMNAALDH1A1HSD17B10L3MBTL1 | |
| SCHEMBL21736346 | 0.87 | SMN1; SMN2 (0.35) | SMN1; SMN2LMNAMEN1ALDH1A1POLB | |
| SCHEMBL21736613 | 0.86 | ALOX5 (0.36) | SMN1; SMN2LMNA | |
| SCHEMBL20669796 | 0.86 | ALDH1A1 (0.32) | SMN1; SMN2LMNAALDH1A1HPGDMAPK1 | |
| SCHEMBL21735899 | 0.86 | SMN1; SMN2 (0.31) | SMN1; SMN2LMNAMEN1ALDH1A1POLB | |
| SCHEMBL21735872 | 0.85 | SMN1; SMN2 (0.34) | SMN1; SMN2LMNAMEN1ALDH1A1POLB | |
| SCHEMBL21478704 | 0.84 | SMN1; SMN2 (0.33) | SMN1; SMN2LMNAMEN1ALDH1A1POLB | |
| SCHEMBL20670002 | 0.83 | CHEK2 (0.35) | SMN1; SMN2LMNAMEN1ALDH1A1HPGD | |
| SCHEMBL21736194 | 0.83 | HCRTR1 (0.33) | SMN1; SMN2LMNAMEN1ALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11530225-B2 | Compound and organic light-emitting diode comprising same | LG CHEM, LTD. (KR) | 2022-12-20 | — | — | US | disclosed |
| US-20200055865-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DIODE COMPRISING SAME | LG CHEM, LTD. (KR) | 2020-02-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11530225-B2 | Compound and organic light-emitting diode comprising same | CRY1, CRY2, TRPA1 | SMN1; SMN2 1814/4885LMNA 3949/4885MEN1 598/4885 |
| US-20200055865-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DIODE COMPRISING SAME | CRY1, CRY2, TRPA1 | SMN1; SMN2 1814/4885LMNA 3949/4885MEN1 598/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.